Nucleus RadioPharma, the radiopharmaceutical-focused contract developing and manufacturing organisation founded by Eclipse ...

A new study published in the Nature journal of Mental Health Research shows powerful real-world evidence for the efficacy of ...

Despite being a rare disease impacting less than a million people worldwide, gMG treatment is an increasingly crowded market, ...

Novo Nordisk has reduced the price of its two semaglutide-based therapies – Ozempic for diabetes and Wegovy for obesity – to a price of $499 for those paying for the drugs out of pocket. The ...

Developing treatments for rare diseases poses many unique challenges that cannot be addressed by traditional study designs.

ChatGPT can't replace humans when it comes to checking patient eligibility to take part in clinical trials, but it can save time and money ...

Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro to bring it into parity with other European markets.

Nicox is on track to file for approval of its NCX 470 therapy for eyesight-robbing disease glaucoma after it showed efficacy in a second pivotal trial. The positive data from the Phase 3 Denali ...

HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.

Hundreds of current and former workers at the Department of Health and Human Services (HHS) have penned a letter to Robert F Kennedy Jr, asking him to stop spreading misinformation that is ...

Targovax interviewed by pharmaphorum said the market for oncolytic viruses is set to get increasingly crowded in the future as pharma tries to use the approach to improve efficacy of checkpoint ...

Celcuity shares rocket on a big win for its lead drug gedatolisib in advanced breast cancer, catapulting its value to almost $1.4 billion.